| # | Drug | Count |
|---|---|---|
| 0 | OLANZAPINE | 10 |
| 1 | BEVACIZUMAB | 5 |
| 2 | FLUOROURACIL | 5 |
| 3 | FLUOROURACIL CREAM, 0.5% | 5 |
| 4 | CAPECITABINE | 3 |
| 5 | DOXORUBICIN | 3 |
| 6 | ESCITALOPRAM | 3 |
| 7 | FAMOTIDINE | 3 |
| 8 | METHOTREXATE | 3 |
| 9 | METHOTREXATE SODIUM | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NALBUPHINE HYDROCHLORIDE | 1 | 0.0044 |
| 1 | GLUTATHIONE | 1 | 0.0006 |
| 2 | DACTINOMYCIN | 1 | 0.0005 |
| 3 | ETODOLAC | 2 | 0.0003 |
| 4 | LEVOLEUCOVORIN INJECTION | 1 | 0.0003 |
| 5 | NADOLOL | 2 | 0.0003 |
| 6 | LEVOLEUCOVORIN | 1 | 0.0003 |
| 7 | VASOPRESSIN | 1 | 0.0002 |
| 8 | CYPROHEPTADINE HYDROCHLORIDE | 1 | 0.0002 |
| 9 | AMLODIPINE BESYLATE AND VALSARTAN | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 1 | 0.0005 |
| 1 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 2 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 4 | Epidermal Growth Factor Receptor Antagonist [EPC] | 2 | 0.0000 |
| 5 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Oxazolidinone Antibacterial [EPC] | 1 | 0.0000 |
| 7 | Glycopeptide Antibacterial [EPC] | 2 | 0.0000 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 8 | 0.0000 |
| 9 | Tetracycline-class Drug [EPC] | 2 | 0.0000 |